Frontiers in Cellular and Infection Microbiology

(The H4-Index of Frontiers in Cellular and Infection Microbiology is 66. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-06-01 to 2024-06-01.)
SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development543
Antibiotics as Major Disruptors of Gut Microbiota385
ACE2, Much More Than Just a Receptor for SARS-COV-2270
Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields225
The PANoptosome: A Deadly Protein Complex Driving Pyroptosis, Apoptosis, and Necroptosis (PANoptosis)222
Antibiotic Resistance: One Health One World Outlook211
Role and Mechanism of Gut Microbiota in Human Disease208
Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) Among Carbapenem-Resistant Enterobacteriaceae Isolated From Adult and Children Patients in China193
Fungi vs. Fungi in Biocontrol: An Overview of Fungal Antagonists Applied Against Fungal Plant Pathogens191
Modern Tools for Rapid Diagnostics of Antimicrobial Resistance168
Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species161
Probiotic Gastrointestinal Transit and Colonization After Oral Administration: A Long Journey154
SARS-COV-2 Variants: Differences and Potential of Immune Evasion148
The Female Vaginal Microbiome in Health and Bacterial Vaginosis130
Periodontal Disease: The Good, The Bad, and The Unknown124
Colon Cancer-Associated Fusobacterium nucleatum May Originate From the Oral Cavity and Reach Colon Tumors via the Circulatory System122
The Gut Microbiota in Inflammatory Bowel Disease120
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria116
Wuhan to World: The COVID-19 Pandemic115
T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression111
Urinary Microbiome: Yin and Yang of the Urinary Tract106
Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome106
Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine106
Association Between ABO Blood Group System and COVID-19 Susceptibility in Wuhan98
Cathepsin L in COVID-19: From Pharmacological Evidences to Genetics98
Development and Validation of a Rapid, Single-Step Reverse Transcriptase Loop-Mediated Isothermal Amplification (RT-LAMP) System Potentially to Be Used for Reliable and High-Throughput Screening of CO98
The Building Blocks of Antimicrobial Resistance in Pseudomonas aeruginosa: Implications for Current Resistance-Breaking Therapies98
Extracellular Vesicles in Fungi: Past, Present, and Future Perspectives96
Promising Therapeutic Strategies Against Microbial Biofilm Challenges95
Recent Updates on Outbreaks of Shiga Toxin-Producing Escherichia coli and Its Potential Reservoirs95
SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro92
Blood-Brain Barrier Disruption by Lipopolysaccharide and Sepsis-Associated Encephalopathy92
Bacterial Vaginosis: Current Diagnostic Avenues and Future Opportunities91
The Role of Porphyromonas gingivalis Outer Membrane Vesicles in Periodontal Disease and Related Systemic Diseases89
Chitosan-Based Nanoparticles Against Viral Infections89
Gut Microbiota and Diarrhea: An Updated Review88
Impact of Gut Microbiota and Microbiota-Related Metabolites on Hyperlipidemia88
Desulfovibrio Bacteria Are Associated With Parkinson’s Disease88
An Update on Molecular Diagnostics for COVID-1986
Mechanism of the Gut Microbiota Colonization Resistance and Enteric Pathogen Infection86
Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus85
Gut Microbiota Status in COVID-19: An Unrecognized Player?84
Recent Advances in Molecular Diagnostics of Fungal Plant Pathogens: A Mini Review83
Dysbiosis and Implication of the Gut Microbiota in Diabetic Retinopathy81
Proteus mirabilis Biofilm: Development and Therapeutic Strategies81
A Novel Scoring System for Prediction of Disease Severity in COVID-1980
Immune Parameters and COVID-19 Infection – Associations With Clinical Severity and Disease Prognosis80
Serum SARS-COV-2 Nucleocapsid Protein: A Sensitivity and Specificity Early Diagnostic Marker for SARS-COV-2 Infection79
Virulence Factors of Pseudomonas Aeruginosa and Antivirulence Strategies to Combat Its Drug Resistance79
The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation77
Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial77
Quorum Sensing, Biofilm, and Intestinal Mucosal Barrier: Involvement the Role of Probiotic76
Antimicrobial Susceptibility Testing of Antimicrobial Peptides to Better Predict Efficacy76
A Human 2D Primary Organoid-Derived Epithelial Monolayer Model to Study Host-Pathogen Interaction in the Small Intestine76
Diversity of Hybrid- and Hetero-Pathogenic Escherichia coli and Their Potential Implication in More Severe Diseases75
Viral Infections, the Microbiome, and Probiotics75
An Overview of Anti-Eukaryotic T6SS Effectors75
Escherichia coli as a Multifaceted Pathogenic and Versatile Bacterium75
Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome71
Structural Variations of Vaginal and Endometrial Microbiota: Hints on Female Infertility70
How to Count Our Microbes? The Effect of Different Quantitative Microbiome Profiling Approaches70
Application of Metagenomic Next-Generation Sequencing in the Diagnosis of Pulmonary Infectious Pathogens From Bronchoalveolar Lavage Samples70
The Impact of Gut Microbiota on Radiation-Induced Enteritis70
Herpes Simplex Virus Cell Entry Mechanisms: An Update69
Contribution of Lactobacillus iners to Vaginal Health and Diseases: A Systematic Review69
The Microbiota of the Human Mammary Ecosystem67
Intrinsic ADE: The Dark Side of Antibody Dependent Enhancement During Dengue Infection66